Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers

Hisayuki Hashimoto, Zhaoning Wang, Glynnis A. Garry, Venkat S. Malladi, Giovanni A. Botten, Wenduo Ye, Huanyu Zhou, Marco Osterwalder, Diane E. Dickel, Axel Visel, Ning Liu, Rhonda Bassel-Duby, Eric N. Olson

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The cardiogenic transcription factors (TFs) Mef2c, Gata4, and Tbx5 can directly reprogram fibroblasts to induced cardiac-like myocytes (iCLMs), presenting a potential source of cells for cardiac repair. While activity of these TFs is enhanced by Hand2 and Akt1, their genomic targets and interactions during reprogramming are not well studied. We performed genome-wide analyses of cardiogenic TF binding and enhancer profiling during cardiac reprogramming. We found that these TFs synergistically activate enhancers highlighted by Mef2c binding sites and that Hand2 and Akt1 coordinately recruit other TFs to enhancer elements. Intriguingly, these enhancer landscapes collectively resemble patterns of enhancer activation during embryonic cardiogenesis. We further constructed a cardiac reprogramming gene regulatory network and found repression of EGFR signaling pathway genes. Consistently, chemical inhibition of EGFR signaling augmented reprogramming. Thus, by defining epigenetic landscapes these findings reveal synergistic transcriptional activation across a broad landscape of cardiac enhancers and key signaling pathways that govern iCLM reprogramming. Hashimoto and colleagues show that reprogramming factors act in concert at cardiac regulatory elements to directly reprogram mouse fibroblasts into induced cardiac-like myocytes (iCLMs). Moreover, cardiac reprogramming is achieved by activation of endogenous cardiac enhancers that initiate a cardiogenic gene regulatory network.

Original languageEnglish
Pages (from-to)69-86.e5
JournalCell stem cell
Volume25
Issue number1
DOIs
Publication statusPublished - 2019 Jul 3
Externally publishedYes

Fingerprint

Transcription Factors
Genome
Cardiac Myocytes
Gene Regulatory Networks
Fibroblasts
Epigenomics
Transcriptional Activation
Binding Sites
Genes

Keywords

  • Akt1
  • cardiomyocytes
  • direct reprogramming
  • Gata4
  • Hand2
  • heart regeneration
  • induced cardiac-like myocytes
  • Mef2c
  • Tbx5

ASJC Scopus subject areas

  • Molecular Medicine
  • Genetics
  • Cell Biology

Cite this

Hashimoto, H., Wang, Z., Garry, G. A., Malladi, V. S., Botten, G. A., Ye, W., ... Olson, E. N. (2019). Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers. Cell stem cell, 25(1), 69-86.e5. https://doi.org/10.1016/j.stem.2019.03.022

Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers. / Hashimoto, Hisayuki; Wang, Zhaoning; Garry, Glynnis A.; Malladi, Venkat S.; Botten, Giovanni A.; Ye, Wenduo; Zhou, Huanyu; Osterwalder, Marco; Dickel, Diane E.; Visel, Axel; Liu, Ning; Bassel-Duby, Rhonda; Olson, Eric N.

In: Cell stem cell, Vol. 25, No. 1, 03.07.2019, p. 69-86.e5.

Research output: Contribution to journalArticle

Hashimoto, H, Wang, Z, Garry, GA, Malladi, VS, Botten, GA, Ye, W, Zhou, H, Osterwalder, M, Dickel, DE, Visel, A, Liu, N, Bassel-Duby, R & Olson, EN 2019, 'Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers', Cell stem cell, vol. 25, no. 1, pp. 69-86.e5. https://doi.org/10.1016/j.stem.2019.03.022
Hashimoto, Hisayuki ; Wang, Zhaoning ; Garry, Glynnis A. ; Malladi, Venkat S. ; Botten, Giovanni A. ; Ye, Wenduo ; Zhou, Huanyu ; Osterwalder, Marco ; Dickel, Diane E. ; Visel, Axel ; Liu, Ning ; Bassel-Duby, Rhonda ; Olson, Eric N. / Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers. In: Cell stem cell. 2019 ; Vol. 25, No. 1. pp. 69-86.e5.
@article{75775f40b78f4a9c8ce86525cb6ff638,
title = "Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers",
abstract = "The cardiogenic transcription factors (TFs) Mef2c, Gata4, and Tbx5 can directly reprogram fibroblasts to induced cardiac-like myocytes (iCLMs), presenting a potential source of cells for cardiac repair. While activity of these TFs is enhanced by Hand2 and Akt1, their genomic targets and interactions during reprogramming are not well studied. We performed genome-wide analyses of cardiogenic TF binding and enhancer profiling during cardiac reprogramming. We found that these TFs synergistically activate enhancers highlighted by Mef2c binding sites and that Hand2 and Akt1 coordinately recruit other TFs to enhancer elements. Intriguingly, these enhancer landscapes collectively resemble patterns of enhancer activation during embryonic cardiogenesis. We further constructed a cardiac reprogramming gene regulatory network and found repression of EGFR signaling pathway genes. Consistently, chemical inhibition of EGFR signaling augmented reprogramming. Thus, by defining epigenetic landscapes these findings reveal synergistic transcriptional activation across a broad landscape of cardiac enhancers and key signaling pathways that govern iCLM reprogramming. Hashimoto and colleagues show that reprogramming factors act in concert at cardiac regulatory elements to directly reprogram mouse fibroblasts into induced cardiac-like myocytes (iCLMs). Moreover, cardiac reprogramming is achieved by activation of endogenous cardiac enhancers that initiate a cardiogenic gene regulatory network.",
keywords = "Akt1, cardiomyocytes, direct reprogramming, Gata4, Hand2, heart regeneration, induced cardiac-like myocytes, Mef2c, Tbx5",
author = "Hisayuki Hashimoto and Zhaoning Wang and Garry, {Glynnis A.} and Malladi, {Venkat S.} and Botten, {Giovanni A.} and Wenduo Ye and Huanyu Zhou and Marco Osterwalder and Dickel, {Diane E.} and Axel Visel and Ning Liu and Rhonda Bassel-Duby and Olson, {Eric N.}",
year = "2019",
month = "7",
day = "3",
doi = "10.1016/j.stem.2019.03.022",
language = "English",
volume = "25",
pages = "69--86.e5",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers

AU - Hashimoto, Hisayuki

AU - Wang, Zhaoning

AU - Garry, Glynnis A.

AU - Malladi, Venkat S.

AU - Botten, Giovanni A.

AU - Ye, Wenduo

AU - Zhou, Huanyu

AU - Osterwalder, Marco

AU - Dickel, Diane E.

AU - Visel, Axel

AU - Liu, Ning

AU - Bassel-Duby, Rhonda

AU - Olson, Eric N.

PY - 2019/7/3

Y1 - 2019/7/3

N2 - The cardiogenic transcription factors (TFs) Mef2c, Gata4, and Tbx5 can directly reprogram fibroblasts to induced cardiac-like myocytes (iCLMs), presenting a potential source of cells for cardiac repair. While activity of these TFs is enhanced by Hand2 and Akt1, their genomic targets and interactions during reprogramming are not well studied. We performed genome-wide analyses of cardiogenic TF binding and enhancer profiling during cardiac reprogramming. We found that these TFs synergistically activate enhancers highlighted by Mef2c binding sites and that Hand2 and Akt1 coordinately recruit other TFs to enhancer elements. Intriguingly, these enhancer landscapes collectively resemble patterns of enhancer activation during embryonic cardiogenesis. We further constructed a cardiac reprogramming gene regulatory network and found repression of EGFR signaling pathway genes. Consistently, chemical inhibition of EGFR signaling augmented reprogramming. Thus, by defining epigenetic landscapes these findings reveal synergistic transcriptional activation across a broad landscape of cardiac enhancers and key signaling pathways that govern iCLM reprogramming. Hashimoto and colleagues show that reprogramming factors act in concert at cardiac regulatory elements to directly reprogram mouse fibroblasts into induced cardiac-like myocytes (iCLMs). Moreover, cardiac reprogramming is achieved by activation of endogenous cardiac enhancers that initiate a cardiogenic gene regulatory network.

AB - The cardiogenic transcription factors (TFs) Mef2c, Gata4, and Tbx5 can directly reprogram fibroblasts to induced cardiac-like myocytes (iCLMs), presenting a potential source of cells for cardiac repair. While activity of these TFs is enhanced by Hand2 and Akt1, their genomic targets and interactions during reprogramming are not well studied. We performed genome-wide analyses of cardiogenic TF binding and enhancer profiling during cardiac reprogramming. We found that these TFs synergistically activate enhancers highlighted by Mef2c binding sites and that Hand2 and Akt1 coordinately recruit other TFs to enhancer elements. Intriguingly, these enhancer landscapes collectively resemble patterns of enhancer activation during embryonic cardiogenesis. We further constructed a cardiac reprogramming gene regulatory network and found repression of EGFR signaling pathway genes. Consistently, chemical inhibition of EGFR signaling augmented reprogramming. Thus, by defining epigenetic landscapes these findings reveal synergistic transcriptional activation across a broad landscape of cardiac enhancers and key signaling pathways that govern iCLM reprogramming. Hashimoto and colleagues show that reprogramming factors act in concert at cardiac regulatory elements to directly reprogram mouse fibroblasts into induced cardiac-like myocytes (iCLMs). Moreover, cardiac reprogramming is achieved by activation of endogenous cardiac enhancers that initiate a cardiogenic gene regulatory network.

KW - Akt1

KW - cardiomyocytes

KW - direct reprogramming

KW - Gata4

KW - Hand2

KW - heart regeneration

KW - induced cardiac-like myocytes

KW - Mef2c

KW - Tbx5

UR - http://www.scopus.com/inward/record.url?scp=85068026823&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85068026823&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2019.03.022

DO - 10.1016/j.stem.2019.03.022

M3 - Article

VL - 25

SP - 69-86.e5

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 1

ER -